Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1377009 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
Abstract
Iressa (Gefitinib) is an orally active inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR-TK) involved in cell signal transduction processes critical to proliferation, apoptosis, repair, and angiogenesis of cancer cells. [11C]Iressa was first designed and synthesized as a new potential positron emission tomography (PET) cancer imaging agent for EGFR-TK in 30–40% radiochemical yield with 4.0–6.0 Ci/μmol specific activity at end of bombardment (EOB).
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Ji-Quan Wang, Mingzhang Gao, Kathy D. Miller, George W. Sledge, Qi-Huang Zheng,